Γ

SynBioBeta Speaker

Guus Gerritsen

MANE Ingredients USA

Managing Director

Guus Gerritsen is an accomplished global business leader with more than three decades of experience spanning manufacturing, supply chain, biotechnology, and specialty ingredients. Guus currently serves as Managing Director of MANE Ingredients USA.

He oversees operations across two specialized U.S. facilities located in North Carolina and Wisconsin. Each site plays a distinct role in MANE’s broader manufacturing and innovation ecosystem. The North Carolina facility focuses on agricultural operations, extraction, purification, and drying processes, while the Wisconsin site specializes in fermentation, bioconversions, and advanced biotechnology practices. Fermentation and bioconversion are central to Gerritsen’s operational footprint at MANE, where controlled microbial fermentation and enzyme- or microbe-driven biotransformation convert renewable feedstocks into high-value aroma, flavor, and nutraceutical intermediates, followed by downstream purification/crystallization to meet tight specifications for consistency, safety, and performance at commercial scale. 

Prior to joining MANE, Guus held several senior leadership roles at Ashland. As General Manager Personal Care and Home Care business and Global VP Home and Oral Care.

Guus began his career with Kao Chemicals Europe, where he spent nearly two decades in supply chain and procurement leadership roles.

Sessions Featuring

Guus

This Year

Main Stage Panel

11:05 AM

-

11:30 AM

Tools & Tech

From AI protein design to real-world commercial impact: powering the next wave of everyday products

For more than a century, everyday products - from detergents and shampoos to textiles and packaging - have relied on petrochemicals and harsh industrial processes. Today, AI-driven protein design is opening a radically different path: creating custom enzymes and biomolecules that outperform traditional chemistry while reducing environmental impact. This session explores how advances in computational protein design and machine learning enable the rational creation of enzymes tailored for home care, personal care, and next-generation materials—moving beyond incremental discovery to purpose-built performance under real industrial conditions. Critically, this highlights how AI-driven design is being translated into commercially deployed products at scale with partners and customers.

Main Stage Panel

11:05 AM

-

11:30 AM

Tools & Tech

From AI protein design to real-world commercial impact: powering the next wave of everyday products

For more than a century, everyday products - from detergents and shampoos to textiles and packaging - have relied on petrochemicals and harsh industrial processes. Today, AI-driven protein design is opening a radically different path: creating custom enzymes and biomolecules that outperform traditional chemistry while reducing environmental impact. This session explores how advances in computational protein design and machine learning enable the rational creation of enzymes tailored for home care, personal care, and next-generation materials—moving beyond incremental discovery to purpose-built performance under real industrial conditions. Critically, this highlights how AI-driven design is being translated into commercially deployed products at scale with partners and customers.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include